The JSE was slightly weaker on Monday morning, with its global peers mixed as prospects for a pick up in economic growth contended with concerns over a number of risks.

US equities climbed on Friday after news that a new oral antiviral treatment for Covid-19 from Merck — a US multinational pharmaceutical company — reduced the risk of hospitalisation or death by 50% for patients with mild or moderate cases. The company disclosed plans to seek emergency authorisation for the treatment...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now